Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Lung Cancer ; 104: 70-74, 2017 02.
Article in English | MEDLINE | ID: mdl-28213004

ABSTRACT

OBJECTIVES: Malignant pleural effusion (MPE) has a poor prognosis. Most patients are treated with tube thoracostomy and sclerotherapy, although its success rate is around 64%. We have investigated intrapleural perfusion with hyperthermic chemotherapy (IPHC) using cisplatin in a study with a pharmacokinetic evaluation. METHODS: Patients with MPE, performance status of 0-1, possibility of good lung expansion and Cr<1.2mg/dL were treated with IPHC. The circuit was filled with 2000mL of normal saline containing cisplatin at a dose of 80mg/m2. Under video-assisted thoracoscopic surgery, the thoracic cavity was filled and perfused at a speed of approximately 1L/min at a temperature of 43°C for 1h. Perfusion solution and plasma samples were periodically collected, and concentrations of protein-unbound (free) platinum, which was the active derivative of cisplatin, and total platinum were determined by flameless atomic absorption spectrometry. RESULTS: Twenty patients with MPE (8 lung cancers, 7 mesotheliomas, and 5 others) were enrolled in this study. Rate of free platinum concentration relative to total platinum concentration in perfusion solution after 1hr IPHC at 43°C was 61.1±12.9%. Area under curve (AUC) of free platinum in the pleural space was calculated to be 26.3µg/mLxh, resulting in complete control of pleural effusion for 3 months after IHPC in all cases (95% confidence interval: 83-100%). While, absorption rate of total platinum from the pleural space was 33.8±17.0% (27.4±13.6mg/m2), and the maximum concentration of total platinum in serum was low, 0.66±0.31µg/mL, resulting in controllable side effects; grade 1 renal toxicity: 6 patients, grade 1 emesis: 7 patients. CONCLUSIONS: IPHC with cisplatin showed favorable pharmacokinetic profiles for an optional treatment to control malignant pleural effusion.


Subject(s)
Cisplatin/pharmacokinetics , Hyperthermia, Induced/methods , Lung Neoplasms/drug therapy , Perfusion/methods , Pleural Cavity/drug effects , Pleural Effusion, Malignant/drug therapy , Thoracic Surgery, Video-Assisted/methods , Adult , Aged , Cisplatin/administration & dosage , Cisplatin/adverse effects , Cisplatin/pharmacology , Female , Humans , Hyperthermia, Induced/adverse effects , Infusions, Intralesional/adverse effects , Infusions, Intralesional/instrumentation , Lung Neoplasms/complications , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Male , Mesothelioma/drug therapy , Middle Aged , Perfusion/adverse effects , Platinum/therapeutic use , Pleural Effusion, Malignant/pathology , Pleural Neoplasms/drug therapy , Prospective Studies
2.
Kyobu Geka ; 63(1): 35-40, 2010 Jan.
Article in Japanese | MEDLINE | ID: mdl-20077830

ABSTRACT

A 59-year old man complaining of right shoulder pain was diagnosed with Pancoast tumor. Chest computed tomography (CT) scan showed a right superior sulcus tumor, 5.8 cm in diameter, invading the middle-posterior compartment of thoracic inlet. Chest magnetic resonance imaging (MRI) sagittal section showed the possibility of infiltration to subclavian artery. The patient received preoperative concurrent chemoradiotyrapy (CCRT) [radiotherapy : 60 Gy/30 Fr, cisplatin and docetaxel], resulting in tumor regression (PR). The patient underwent right upper lobectomy and resection of the 1st- 2nd ribs and Th1 nerve via transmanubrial approach and high posterior thoracotomy. Pathological examination demonstrated a little live cancer cells and organization of necrotic tissue in the lung and inter costal region (Ef2). Transmanubrial osteomuscular sparing technique maintains an excellent exposure of thoracic inlet and cervical structures safely.


Subject(s)
Lung Neoplasms/therapy , Pancoast Syndrome/therapy , Chemotherapy, Adjuvant , Humans , Male , Middle Aged , Radiotherapy, Adjuvant , Thoracotomy/methods
3.
Proc Natl Acad Sci U S A ; 98(5): 2199-204, 2001 Feb 27.
Article in English | MEDLINE | ID: mdl-11226216

ABSTRACT

We have systematically characterized gene expression patterns in 49 adult and embryonic mouse tissues by using cDNA microarrays with 18,816 mouse cDNAs. Cluster analysis defined sets of genes that were expressed ubiquitously or in similar groups of tissues such as digestive organs and muscle. Clustering of expression profiles was observed in embryonic brain, postnatal cerebellum, and adult olfactory bulb, reflecting similarities in neurogenesis and remodeling. Finally, clustering genes coding for known enzymes into 78 metabolic pathways revealed a surprising coordination of expression within each pathway among different tissues. On the other hand, a more detailed examination of glycolysis revealed tissue-specific differences in profiles of key regulatory enzymes. Thus, by surveying global gene expression by using microarrays with a large number of elements, we provide insights into the commonality and diversity of pathways responsible for the development and maintenance of the mammalian body plan.


Subject(s)
Gene Expression Profiling , Oligonucleotide Array Sequence Analysis , Animals , Base Sequence , Central Nervous System/metabolism , DNA Primers , DNA, Complementary , Gene Expression Regulation, Developmental , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...